News
MS disease activity returns in one-third after fingolimod withdrawal
BERLIN – Risk factors for higher disease activity include younger age at diagnosis, shorter disease duration, and stopping more than 2 months...
News
Bortezomib may unlock resistance in WM with mutations
The study tested how a bortezomib treatment combination would perform in patients with CXCR4 mutations.
News
CKD, and even dialysis, may not be barriers to pregnancy
Nephrologist urges colleagues to get a grip on how to counsel patients of child-bearing age.
Opinion
CMS modifies the inpatient admission order requirement, or did it?
Medicare auditors have been given discretion to overlook an inpatient order flaw, but providers have not.
News
High rates of HCV treatment completion seen in people who inject drugs
Treatment of people who inject drugs will help prevent new cases of HCV, study coauthor maintains.
News
Despite declines in prenatal use of alcohol and cigarettes, cannabis use is on the rise
Public education concerning the effects that prenatal cannabis use may have on infant health is warranted.
News
Single-port robotic sacrocolpopexy has same learning curve as multiport
LAS VEGAS – This finding came from comparison of the first 52 cases with each type of procedure.
News
Anti-MOG antibodies associated with non-MS, monophasic demyelinating disease in young children
BERLIN – Age and anti-MOG antibody status may help to predict a non-MS diagnosis.
News
FDA approves Primatene Mist return
The over-the-counter bronchodilator is back – and so is the controversy.
News
Antibiotic-obesity link ‘clinically insignificant’ at age 10 years
NASHVILLE, TENN. – Good news” from a large longitudinal cohort study.